98 related articles for article (PubMed ID: 38486047)
1. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
2. The hallucinogenic world of tryptamines: an updated review.
Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties.
Puigseslloses P; Nadal-Gratacós N; Ketsela G; Weiss N; Berzosa X; Estrada-Tejedor R; Islam MN; Holy M; Niello M; Pubill D; Camarasa J; Escubedo E; Sitte HH; López-Arnau R
Mol Psychiatry; 2024 Mar; ():. PubMed ID: 38486047
[TBL] [Abstract][Full Text] [Related]
4. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
5. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.
Kalirajan R; Rishabh K; Srikanth J; Niharika M; Preeya N; Rezaul I
Arch Razi Inst; 2023 Oct; 78(5):1603-1614. PubMed ID: 38590677
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.
Abiero A; Botanas CJ; Sayson LV; Custodio RJ; de la Peña JB; Kim M; Lee HJ; Seo JW; Ryu IS; Chang CM; Yang JS; Lee YS; Jang CG; Kim HJ; Cheong JH
Behav Brain Res; 2019 Feb; 359():828-835. PubMed ID: 30053461
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic mechanisms of psychedelics and entactogens.
Heifets BD; Olson DE
Neuropsychopharmacology; 2024 Jan; 49(1):104-118. PubMed ID: 37488282
[TBL] [Abstract][Full Text] [Related]
9. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)
Kozell LB; Eshleman AJ; Swanson TL; Bloom SH; Wolfrum KM; Schmachtenberg JL; Olson RJ; Janowsky A; Abbas AI
J Pharmacol Exp Ther; 2023 Apr; 385(1):62-75. PubMed ID: 36669875
[TBL] [Abstract][Full Text] [Related]
11. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE
ACS Chem Neurosci; 2023 Feb; 14(3):351-358. PubMed ID: 36630260
[TBL] [Abstract][Full Text] [Related]
12. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.
Shahar O; Botvinnik A; Esh-Zuntz N; Brownstien M; Wolf R; Lotan A; Wolf G; Lerer B; Lifschytz T
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430623
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-releasing agents with reduced off-target effects.
Mayer FP; Niello M; Cintulova D; Sideromenos S; Maier J; Li Y; Bulling S; Kudlacek O; Schicker K; Iwamoto H; Deng F; Wan J; Holy M; Katamish R; Sandtner W; Li Y; Pollak DD; Blakely RD; Mihovilovic MD; Baumann MH; Sitte HH
Mol Psychiatry; 2023 Feb; 28(2):722-732. PubMed ID: 36352123
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.
López-Arnau R; Camarasa J; Carbó ML; Nadal-Gratacós N; Puigseslloses P; Espinosa-Velasco M; Urquizu E; Escubedo E; Pubill D
Front Psychiatry; 2022; 13():990405. PubMed ID: 36262632
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
